Delivery Order SPE2DR25D1202-SPE2DR26F74CM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Phenobarbital 130 mg/mL vials valued at $2,123.64 under a firm fixed price contract. The award was made on November 17, 2025, with an ultimate completion date of November 18, 2025, and is classified as a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,772.04 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL in vial form. This non-set-aside, competitively awarded contract was issued on January 16, 2026, with an ultimate completion date of January 20, 2026. The pharmaceutical product will be delivered to the awardee's location in Conshohocken, Pennsylvania. This delivery order is structured as a firm fixed-price contract, reflecting DLA's standard...
- The Defense Logistics Agency awarded a delivery order valued at $9,470.98 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/ml vials. The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitive award under AmerisourceBergen's existing federal contract portfolio and will be performed at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,839.58 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of December 22, 2025, and represents a single delivery order under AmerisourceBergen's larger federal contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a $7,103.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/ml in vial format. The contract was competitively awarded without set-aside designation and is scheduled for completion by October 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,089.00 for Phenobarbital 65 mg/mL vials by the Defense Department's Medical Supply Chain. This contract, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes firm fixed price contracting and was awarded competitively with no set-aside designation. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,488 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Phenobarbital 130 mg/mL vials. This competitively awarded, firm fixed-price contract is not set aside for any specific business category and is scheduled for completion by July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,854.29 on January 19, 2026, for the supply of Phenobarbital 65mg tablets (25-count packages) to the Defense Logistics Agency. This firm fixed-price delivery order, with an ultimate completion date of January 20, 2026, was competitively awarded without any set-aside designation. The contract represents a task order under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,336.62 on December 29, 2025, for the supply of Phenobarbital 130 mg/mL vials. This competitively awarded, firm fixed-price contract is non-set-aside and scheduled for completion by December 30, 2025. AmerisourceBergen Drug Corp will perform this work at its corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $3,285.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Phenobarbital 130 mg/ml vials. The contract represents a non-set-aside competitive award with an ultimate completion date of August 29, 2025, and performance location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F74CMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,060.19 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/ml vials. The contract, awarded on January 18, 2026, with an ultimate completion date of January 20, 2026, represents a firm fixed-price purchase under a non-set-aside competitive procurement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Through its primary IDC with DLA, AmerisourceBergen is positioned to fulfill diverse medical supply requirements for military treatment facilities and veterans' healthcare programs, with this specific delivery order for phenobarbital supporting neurological treatment needs within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/17/26 |